Transplantation of Reduced-Size Fatty Livers

缩小脂肪肝移植

基本信息

  • 批准号:
    7626375
  • 负责人:
  • 金额:
    $ 25.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-06-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Fatty livers are rarely used for partial liver transplantation due to the fear of primary non-function. These studies are to elucidate mechanisms and to develop strategies to prevent failure of fatty partial grafts. We will use reduced-size rat liver transplantation to test the unique hypotheses that steatosis and partial liver transplantation synergistically increase reactive oxygen and nitrogen species (ROS and RNS), inhibit mitochondrial function and suppress liver regeneration. In Aim 1, we will investigate if steatosis increases graft failure after partial liver transplantation. Fatty livers will be induced by high fat diet and choline-deficient diet, respectively, and reduced to 30% to 50% of original size. We will assess survival, liver function, and histology after transplantation as a function of steatosis, graft volume and cold storage time. In Aim 2, we will test the hypothesis that ROS and RNS are increased in high-fat diet-induced fatty partial grafts, leading to injury. ROS will be determined by the spin-trapping technique and immunohistochemistry for 4-hydroxynonenal and RNS will be assessed as nitrotyrosine and nitrite/nitrate levels. We expect that ROS and RNS production will be higher in fatty than lean partial grafts. We will also identify cellular sources of ROS and RNS using fluorescent intravital multiphoton microscopy. The effects of antioxidants (Ad-superoxide dismutase, N-acetylcysteine and polyphenols) and antinitrative therapies (nitric oxide synthase inhibitors) on survival and injury of fatty partial grafts will be evaluated. In Aim 3, effects of steatosis and graft volume on energy supply will be evaluated. Uncoupling protein 2, mitochondrial permeability transition and respiratory chain activity will be determined to elucidate the mechanisms of defective energy production, and effects of mitochondrial permeability transition inhibitors and antioxidant and antinitrative therapies on mitochondrial function will be evaluated. In Aim 4, the effects of steatosis and graft volume on liver regeneration will be assessed. Cell proliferation and factors regulating regeneration (cytokines, transcription factors, growth factors, and cell cycle related genes) will be evaluated. In addition, we will investigate if protection of mitochondria function and antioxidative and antinitrative therapies improve liver regeneration. Taken together, we expect that this work will provide fundamental new insights into the mechanisms underlying reduced-size fatty graft failure and develop mechanism-based strategies to increase the use and improve the outcome of fatty livers for partial liver transplantation in the clinic.
描述(由申请人提供):由于担心原发性无功能,脂肪肝很少用于部分肝移植。这些研究旨在阐明脂肪部分移植失败的机制,并制定预防脂肪部分移植失败的策略。我们将使用缩小体积的大鼠肝移植来测试脂肪变性和部分肝移植协同增加活性氧和氮(ROS和RNS),抑制线粒体功能和抑制肝再生的独特假设。在目标1中,我们将研究部分肝移植后脂肪变性是否会增加移植物衰竭。分别用高脂饮食和胆碱缺乏饮食诱发脂肪肝,并使脂肪肝缩小到原来的30%~ 50%。我们将评估移植后的存活率、肝功能和组织学,作为脂肪变性、移植物体积和冷藏时间的函数。在目标2中,我们将检验高脂饮食诱导的脂肪部分移植物中ROS和RNS增加导致损伤的假设。将通过自旋捕获技术测定ROS,并对4-羟基壬烯醛和RNS进行免疫组织化学评估,作为硝基酪氨酸和亚硝酸盐/硝酸盐水平。我们预计脂肪肝移植的ROS和RNS的产生要高于瘦肉肝移植。我们还将使用荧光活体多光子显微镜鉴定ROS和RNS的细胞来源。将评价抗氧化剂(Ad-超氧化物歧化酶、N-乙酰半胱氨酸和多酚)和抗硝化疗法(一氧化氮合酶抑制剂)对脂肪部分移植物存活和损伤的影响。在目标3中,将评价脂肪变性和移植物体积对能量供应的影响。将测定解偶联蛋白2、线粒体渗透性转换和呼吸链活性,以阐明能量产生缺陷的机制,并评价线粒体渗透性转换抑制剂以及抗氧化剂和抗硝酸盐治疗对线粒体功能的影响。在目标4中,将评估脂肪变性和移植物体积对肝再生的影响。将评价细胞增殖和调节再生的因子(细胞因子、转录因子、生长因子和细胞周期相关基因)。此外,我们还将研究线粒体功能的保护以及抗氧化和抗硝化治疗是否能改善肝再生。综上所述,我们期望这项工作将为缩小脂肪肝移植失败的机制提供基本的新见解,并制定基于机制的策略,以增加脂肪肝在临床部分肝移植中的使用并改善其结果。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ZHI ZHONG其他文献

ZHI ZHONG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ZHI ZHONG', 18)}}的其他基金

Transplantation of Reduced-Size Fatty Livers
缩小脂肪肝移植
  • 批准号:
    8012891
  • 财政年份:
    2010
  • 资助金额:
    $ 25.63万
  • 项目类别:
Mechanisms of In Vivo Ethanol-Induced Mitochondrial Depolarization
体内乙醇诱导线粒体去极化的机制
  • 批准号:
    7522902
  • 财政年份:
    2009
  • 资助金额:
    $ 25.63万
  • 项目类别:
Mechanisms of In Vivo Ethanol-Induced Mitochondrial Depolarization
体内乙醇诱导线粒体去极化的机制
  • 批准号:
    7896824
  • 财政年份:
    2009
  • 资助金额:
    $ 25.63万
  • 项目类别:
Improvement of Liver Transplantation by a Sphingosine Kinase Inhibitor
鞘氨醇激酶抑制剂改善肝移植
  • 批准号:
    7745865
  • 财政年份:
    2009
  • 资助金额:
    $ 25.63万
  • 项目类别:
Transplantation of Reduced-Size Fatty Livers
缩小脂肪肝移植
  • 批准号:
    7103971
  • 财政年份:
    2006
  • 资助金额:
    $ 25.63万
  • 项目类别:
Transplantation of Reduced-Size Fatty Livers
缩小脂肪肝移植
  • 批准号:
    7233696
  • 财政年份:
    2006
  • 资助金额:
    $ 25.63万
  • 项目类别:
Transplantation of Reduced-Size Fatty Livers
缩小脂肪肝移植
  • 批准号:
    7430496
  • 财政年份:
    2006
  • 资助金额:
    $ 25.63万
  • 项目类别:
Improving Survival For Small-For-Size Liver Grafts
提高小型肝移植物的存活率
  • 批准号:
    6752765
  • 财政年份:
    2002
  • 资助金额:
    $ 25.63万
  • 项目类别:
Improving Survival For Small-For-Size Liver Grafts
提高小型肝移植物的存活率
  • 批准号:
    6521489
  • 财政年份:
    2002
  • 资助金额:
    $ 25.63万
  • 项目类别:
Improving Survival For Small-For-Size Liver Grafts
提高小型肝移植物的存活率
  • 批准号:
    6611398
  • 财政年份:
    2002
  • 资助金额:
    $ 25.63万
  • 项目类别:

相似海外基金

Relationship between 4-Hydroxynonenal and Agitation Severity in Alzheimer’s Disease
4-羟基壬烯醛与阿尔茨海默病患者躁动严重程度之间的关系
  • 批准号:
    486589
  • 财政年份:
    2022
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Studentship Programs
Investigating the role of red blood cells in oxidative stress and thrombogenesis - from 4-hydroxynonenal chemistry to mouse to man.
研究红细胞在氧化应激和血栓形成中的作用 - 从 4-羟基壬烯醛化学到小鼠再到人类。
  • 批准号:
    304797
  • 财政年份:
    2014
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Operating Grants
Protein modification by 4-hydroxynonenal (HNE) modulates cell function: identification of specific proteins as cellular targets of HNE binding
4-羟基壬烯醛 (HNE) 的蛋白质修饰调节细胞功能:鉴定特定蛋白质作为 HNE 结合的细胞靶标
  • 批准号:
    341797-2010
  • 财政年份:
    2014
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Discovery Grants Program - Individual
Protein modification by 4-hydroxynonenal (HNE) modulates cell function: identification of specific proteins as cellular targets of HNE binding
4-羟基壬烯醛 (HNE) 的蛋白质修饰调节细胞功能:鉴定特定蛋白质作为 HNE 结合的细胞靶标
  • 批准号:
    341797-2010
  • 财政年份:
    2013
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Discovery Grants Program - Individual
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.
通过控制活性醛 4-羟基壬烯醛的水平,靶向结直肠癌起始细胞和抗 EGFR 治疗耐药性。
  • 批准号:
    302201
  • 财政年份:
    2013
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Salary Programs
Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal
通过控制活性醛 4-羟基壬烯醛的水平,靶向结直肠癌起始细胞和抗 EGFR 治疗耐药性
  • 批准号:
    281581
  • 财政年份:
    2013
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Operating Grants
The lipid peroxidation product 4-hydroxynonenal in the pathophysiology of osteoarthritis
脂质过氧化产物4-羟基壬烯醛在骨关节炎病理生理学中的作用
  • 批准号:
    286322
  • 财政年份:
    2013
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Operating Grants
Role of 4-hydroxynonenal in n-6 polyunsaturated fatty acid induced cytoxicity in cardiac cells
4-羟基壬烯醛在 n-6 多不饱和脂肪酸诱导的心肌细胞细胞毒性中的作用
  • 批准号:
    427447-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Postgraduate Scholarships - Master's
Protein modification by 4-hydroxynonenal (HNE) modulates cell function: identification of specific proteins as cellular targets of HNE binding
4-羟基壬烯醛 (HNE) 的蛋白质修饰调节细胞功能:鉴定特定蛋白质作为 HNE 结合的细胞靶标
  • 批准号:
    341797-2010
  • 财政年份:
    2012
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Discovery Grants Program - Individual
Role of 4-hydroxynonenal in n-6 polyunsaturated fatty acid induced cytoxicity in cardiac cells
4-羟基壬烯醛在 n-6 多不饱和脂肪酸诱导的心肌细胞细胞毒性中的作用
  • 批准号:
    427447-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 25.63万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了